The move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are investing in modelling tools and automated laboratories to shorten development timelines and improve efficiency.
The move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are investing in modelling tools and automated laboratories to shorten development timelines and improve efficiency.
<iframe src="https://hindustansphere.com/embed/cluster/5f75fec1da71275396796259868c8fb2b1fd4f9f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Huawei plans for more AI pharma tie-ups, says healthcare president"></iframe>
